Healthy Living Arizona: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Arizona.

Press releases published on July 8, 2026

Jul. 8, 2026

Satellos Reports Six-Month Interim TRAILHEAD Data Showing Reduced Muscle Fat Fraction, Increased Effort, Stable Strength, Lower CK and Favorable Safety Profile in DMD Adults Treated with SAT-3247

Indeterminate GlobeNewswire

Jul. 8, 2026

Despite Physician Enthusiasm, Wearable Data Adoption Stalled by System Barriers

Indeterminate GlobeNewswire

Jul. 8, 2026

J-Star Holding Holding Co., Ltd Announces 1-for-5 Share Consolidation

Indeterminate GlobeNewswire

Jul. 8, 2026

Nonprofit Launches One of the Nation’s Most Comprehensive Education Resources for Inherited Retinal Diseases

Indeterminate GlobeNewswire

Jul. 8, 2026

AMSilk and Ajinomoto Foods Europe Expand Partnership to Enable Industrial-Scale Production of Silk Proteins

Indeterminate GlobeNewswire

Jul. 8, 2026

Dumbo Health Launches SleepLongevityAge, Bringing Clinical Care to the World’s Most Overlooked Health Metric

Indeterminate GlobeNewswire

Jul. 8, 2026

Tensive appoints Peter Crosby Chairman as its bioresorbable breast reconstruction scaffold approaches regulatory approval

Indeterminate GlobeNewswire

Jul. 8, 2026

On World Obesity Day, WONDERLAB Releases the Targeted Microbiota Weight Management White Paper

Indeterminate GlobeNewswire

Jul. 8, 2026

Avacta Appoints Healthcare Executive Patrick Vink as Deputy Chairman of the Board of Directors

Indeterminate GlobeNewswire

Jul. 8, 2026

Addex Announces Publication of Research Highlighting Therapeutic Potential of mGlu7 Modulation in Regulating Sleep and Wakefulness

Indeterminate GlobeNewswire

Jul. 8, 2026

LincNutri Launches NAD+ Supplement for Women, Expanding Its Healthy Aging Portfolio with Multi-Ingredient Cellular Support

Indeterminate GlobeNewswire

Jul. 8, 2026

Vivani Medical schließt Vereinbarung mit Novo Nordisk zur Evaluierung von NPM-139, einem miniaturisierten, ultra-langwirkenden Semaglutid-Implantat zur langfristigen Gewichtsregulierung

Indeterminate GlobeNewswire

Jul. 8, 2026

Vivani Medical conclut un accord avec Novo Nordisk pour évaluer le NPM-139, un implant miniature à base de sémaglutide à action ultra-prolongée destiné au traitement de l’obésité

Indeterminate GlobeNewswire

Jul. 8, 2026

Vivani Medical Mengadakan Perjanjian dengan Novo Nordisk untuk Mengevaluasi NPM-139, Implan Semaglutide Miniatur dengan Kerja Sangat Panjang untuk Pengelolaan Berat Badan Kronis

Indeterminate GlobeNewswire

Jul. 8, 2026

ヴィヴァニ・メディカル、慢性体重管理のためのセマグルチドの超長時間作用小型インプラント「NPM-139」の評価に向け、ノボ ノルディスクと契約を締結

Indeterminate GlobeNewswire

Jul. 8, 2026

Vivani Medical, 만성 체중관리용 초장기 지속형 세마글루타이드 임플란트 'NPM-139' 평가 위해 Novo Nordisk와 계약 체결

Indeterminate GlobeNewswire

Jul. 8, 2026

Vivani Medical Menandatangani Perjanjian dengan Novo Nordisk bagi Menilai NPM-139, Implan Semaglutide Miniatur dengan Tindakan Ultra Jangka Panjang bagi Pengurusan Berat Badan Kronik

Indeterminate GlobeNewswire

Jul. 8, 2026

Vivani Medical เข้าทำข้อตกลงกับ Novo Nordisk เพื่อประเมิน NPM-139…

Indeterminate GlobeNewswire

Jul. 8, 2026

Vivani Medical 与 Novo Nordisk 达成协议，评估用于长期体重管理的微型超长效司美格鲁肽植入剂 NPM-139

Indeterminate GlobeNewswire

Jul. 8, 2026

Vivani Medical 與 Novo Nordisk 達成協議，評估一種微型、超長效並用於慢性體重管理的司美格魯肽植入劑 NPM-139

Indeterminate GlobeNewswire